Evaluation of the corrective effect of therapeutic plasmapheresis on the state of renal function in patients after surgical treatment of localized kidney cancer

Purpose of the study. To assess the state of renal function in the application of therapeutic plasmapheresis in order to correct the disorders accompanying the development of preclinical stage of AKI in patients after partial nephrectomy under conditions of warm ischemia.Patients and methods. We exa...

Full description

Bibliographic Details
Main Authors: S. N. Dimitriadi, N. D. Ushakova, A. V. Velichko, E. M. Frantsiyants
Format: Article
Language:Russian
Published: ANO "Perspective of oncology" 2021-06-01
Series:Южно-Российский онкологический журнал
Subjects:
Online Access:https://www.cancersp.com/jour/article/view/97
_version_ 1797882868066680832
author S. N. Dimitriadi
N. D. Ushakova
A. V. Velichko
E. M. Frantsiyants
author_facet S. N. Dimitriadi
N. D. Ushakova
A. V. Velichko
E. M. Frantsiyants
author_sort S. N. Dimitriadi
collection DOAJ
description Purpose of the study. To assess the state of renal function in the application of therapeutic plasmapheresis in order to correct the disorders accompanying the development of preclinical stage of AKI in patients after partial nephrectomy under conditions of warm ischemia.Patients and methods. We examined 119 patients (average aged 57.6±7.8 years) from 2018 to 2019, who underwent open or laparoscopic kidney resection for cancer according to elective indications and with the usage of standard WIT technique within 15-21 minutes. Patients with a high risk of developing a clinical stage of AKI (n=21) were divided into 2 groups: in group I (n=10), patients continued to receive standard nephroprotective therapy, in group II (n=11), 24 hours after surgery, therapeutic plasmapheresis was performed according to the TPE (Therapeutic plasma exchange) protocol. During 7 days after the surgery patients in both groups were monitored daily for the rate of hourly diuresis, serum creatinine, and creatinine GFR. The presence of significant differences in the groups was evaluated using the STATISTICA 12.6 software package and the differences between the samples were considered significant at p<0.05.Results. The development of the clinical stage of AKI in group I was detected in 80.0 % of cases, in group II in 9.0 % of patients (p=0.0019). The rate of diuresis in group II was significantly higher: by more than 2 times by day 3, by 90.0 % on day 4, by 81.4 % on day 5, by 36.8 % on day 6, and by 25.4 % on day 7 (p<0.05). The average increase in creatinine in group I was significantly higher: more than 5 times on day 5 and more than 4 times on day 6 and 7 of the study (p<0.05). GFR in group II was significantly higher on day 3 (65.3 %), day 5 (54 %), day 6 (39.2 %) and day 7 (50 %) (p<0.05).Conclusion. Therapeutic plasmapheresis is highly effective in the correction of renal function disorders after kidney resection under WIT conditions and demonstrates an advantage in reducing the risk of developing a clinical stage of AKI in comparison with preventive measures that include standard nephroprotective infusion therapy.
first_indexed 2024-04-10T03:42:29Z
format Article
id doaj.art-44e6880eed9140bea677babddb45030a
institution Directory Open Access Journal
issn 2686-9039
language Russian
last_indexed 2024-04-10T03:42:29Z
publishDate 2021-06-01
publisher ANO "Perspective of oncology"
record_format Article
series Южно-Российский онкологический журнал
spelling doaj.art-44e6880eed9140bea677babddb45030a2023-03-13T07:19:28ZrusANO "Perspective of oncology"Южно-Российский онкологический журнал2686-90392021-06-012261410.37748/2686-9039-2021-2-2-136Evaluation of the corrective effect of therapeutic plasmapheresis on the state of renal function in patients after surgical treatment of localized kidney cancerS. N. Dimitriadi0N. D. Ushakova1A. V. Velichko2E. M. Frantsiyants3ФГБУ «НМИЦ онкологии» Минздрава РоссииФГБУ «НМИЦ онкологии» Минздрава РоссииФГБУ «НМИЦ онкологии» Минздрава РоссииФГБУ «НМИЦ онкологии» Минздрава РоссииPurpose of the study. To assess the state of renal function in the application of therapeutic plasmapheresis in order to correct the disorders accompanying the development of preclinical stage of AKI in patients after partial nephrectomy under conditions of warm ischemia.Patients and methods. We examined 119 patients (average aged 57.6±7.8 years) from 2018 to 2019, who underwent open or laparoscopic kidney resection for cancer according to elective indications and with the usage of standard WIT technique within 15-21 minutes. Patients with a high risk of developing a clinical stage of AKI (n=21) were divided into 2 groups: in group I (n=10), patients continued to receive standard nephroprotective therapy, in group II (n=11), 24 hours after surgery, therapeutic plasmapheresis was performed according to the TPE (Therapeutic plasma exchange) protocol. During 7 days after the surgery patients in both groups were monitored daily for the rate of hourly diuresis, serum creatinine, and creatinine GFR. The presence of significant differences in the groups was evaluated using the STATISTICA 12.6 software package and the differences between the samples were considered significant at p<0.05.Results. The development of the clinical stage of AKI in group I was detected in 80.0 % of cases, in group II in 9.0 % of patients (p=0.0019). The rate of diuresis in group II was significantly higher: by more than 2 times by day 3, by 90.0 % on day 4, by 81.4 % on day 5, by 36.8 % on day 6, and by 25.4 % on day 7 (p<0.05). The average increase in creatinine in group I was significantly higher: more than 5 times on day 5 and more than 4 times on day 6 and 7 of the study (p<0.05). GFR in group II was significantly higher on day 3 (65.3 %), day 5 (54 %), day 6 (39.2 %) and day 7 (50 %) (p<0.05).Conclusion. Therapeutic plasmapheresis is highly effective in the correction of renal function disorders after kidney resection under WIT conditions and demonstrates an advantage in reducing the risk of developing a clinical stage of AKI in comparison with preventive measures that include standard nephroprotective infusion therapy.https://www.cancersp.com/jour/article/view/97почечно-клеточный ракострое повреждение почекбиомаркеры почечного повреждениялечебный плазмаферезфункция почкирезекция почки
spellingShingle S. N. Dimitriadi
N. D. Ushakova
A. V. Velichko
E. M. Frantsiyants
Evaluation of the corrective effect of therapeutic plasmapheresis on the state of renal function in patients after surgical treatment of localized kidney cancer
Южно-Российский онкологический журнал
почечно-клеточный рак
острое повреждение почек
биомаркеры почечного повреждения
лечебный плазмаферез
функция почки
резекция почки
title Evaluation of the corrective effect of therapeutic plasmapheresis on the state of renal function in patients after surgical treatment of localized kidney cancer
title_full Evaluation of the corrective effect of therapeutic plasmapheresis on the state of renal function in patients after surgical treatment of localized kidney cancer
title_fullStr Evaluation of the corrective effect of therapeutic plasmapheresis on the state of renal function in patients after surgical treatment of localized kidney cancer
title_full_unstemmed Evaluation of the corrective effect of therapeutic plasmapheresis on the state of renal function in patients after surgical treatment of localized kidney cancer
title_short Evaluation of the corrective effect of therapeutic plasmapheresis on the state of renal function in patients after surgical treatment of localized kidney cancer
title_sort evaluation of the corrective effect of therapeutic plasmapheresis on the state of renal function in patients after surgical treatment of localized kidney cancer
topic почечно-клеточный рак
острое повреждение почек
биомаркеры почечного повреждения
лечебный плазмаферез
функция почки
резекция почки
url https://www.cancersp.com/jour/article/view/97
work_keys_str_mv AT sndimitriadi evaluationofthecorrectiveeffectoftherapeuticplasmapheresisonthestateofrenalfunctioninpatientsaftersurgicaltreatmentoflocalizedkidneycancer
AT ndushakova evaluationofthecorrectiveeffectoftherapeuticplasmapheresisonthestateofrenalfunctioninpatientsaftersurgicaltreatmentoflocalizedkidneycancer
AT avvelichko evaluationofthecorrectiveeffectoftherapeuticplasmapheresisonthestateofrenalfunctioninpatientsaftersurgicaltreatmentoflocalizedkidneycancer
AT emfrantsiyants evaluationofthecorrectiveeffectoftherapeuticplasmapheresisonthestateofrenalfunctioninpatientsaftersurgicaltreatmentoflocalizedkidneycancer